Here’s what drives us:
37 Million
people living with HIV/AIDS worldwide (1.8 million children).
18 Million
new cancer cases in 2018 with 9.5 million deaths worldwide.
$350,000+
Is the cost of a CAR-T cell therapy for Lymphoma, not including hospital costs.
Potentially life-saving advanced therapies are available, but they are neither affordable nor accessible to millions of patients.
Access to life-saving advanced therapies should be a human right for all in need, not just for the privileged few.
Here’s how we do it:
Safe, effective and affordable advanced therapies.
We develop improved advanced therapies and innovative manufacturing processes to lower their cost.
Strategic collaboration.
We partner with a diverse array of stakeholders that support our vision of affordable access to advanced therapies worldwide.
Enabling access.
We support hospitals and health systems to manufacture advanced therapy products close to where patients come for care, improving access.
Every person should be able to access affordable advanced medicines.
Here’s how you can help:
Partner with us.
Help us develop improved advanced therapies and increase their affordability and access for the patients that need them.
Spread the word.
Follow and share our content on your social media channels.
